Compounds derived from imidazo 1,2-b pyridazine hydrochloride and imidazo 4,5-b pyridineAs inhibitors of jak; Pharmaceutical composition that comprises; Product Mix; and their use in the treatment of Leukemia, myeloproliferative diseases,Immune mediated diseases and inflammatory diseases, among others.

摘要

New imidazo[1,2-b]pyridazine derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).